Aberrant DNA Methylations in Chondrosarcoma

References

• Jiao G , GuoW , RenTet al. BMPR2 inhibition induced apoptosis and autophagy via destabilization of XIAP in human chondrosarcoma cells . Cell Death Dis.5 , e1571 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• O’Neal LW , AckermanLV . Chondrosarcoma of bone . Cancer5 ( 3 ), 551 – 577 ( 1952 ).
   PubMed Web of Science ®Google Scholar
• Bauer HC , BrosjoO , KreicbergsA , LindholmJ . Low risk of recurrence of enchondroma and low-grade chondrosarcoma in extremities. 80 patients followed for 2–25 years . Acta Orthop. Scand.66 ( 3 ), 283 – 288 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Eriksson AI , SchillerA , MankinHJ . The management of chondrosarcoma of bone . Clin. Orthop. Relat. Res.153 , 44 – 66 ( 1980 ).
   Google Scholar
• Totoki Y , YoshidaA , HosodaFet al. Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma . Genome Res.24 ( 9 ), 1411 – 1420 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Soderstrom M , EkforsTO , BohlingTO , TeppoLH , VuorioEI , AroHT . No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971–1990 . Acta Orthop. Scand.74 ( 3 ), 344 – 350 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Giuffrida AY , BurguenoJE , KoniarisLG , GutierrezJC , DuncanR , ScullySP . Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database . J. Bone Joint Surg. Am.91 ( 5 ), 1063 – 1072 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yu X , LiZ . Epigenetic deregulations in chordoma . Cell Prolif.48 ( 5 ), 497 – 502 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Esteller M . Epigenetics in cancer . N. Engl. J. Med.358 ( 11 ), 1148 – 1159 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Nervi C , De MarinisE , Codacci-PisanelliG . Epigenetic treatment of solid tumours: a review of clinical trials . Clin. Epigenetics7 , 127 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ouadid-Ahidouch H , Rodat-DespoixL , MatifatF , MorinG , AhidouchA . DNA methylation of channel-related genes in cancers . Biochim. Biophys. Acta.1848 ( 10 Pt B ), 2621 – 2628 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bestor TH . Gene silencing as a threat to the success of gene therapy . J. Clin. Invest.105 ( 4 ), 409 – 411 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Mann DA . Epigenetics in liver disease . Hepatology60 ( 4 ), 1418 – 1425 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bergman Y , CedarH . DNA methylation dynamics in health and disease . Nat. Struct. Mol. Biol.20 ( 3 ), 274 – 281 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cedar H , BergmanY . Programming of DNA methylation patterns . Annu. Rev. Biochem.81 , 97 – 117 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Feinberg AP , VogelsteinB . Hypomethylation distinguishes genes of some human cancers from their normal counterparts . Nature301 ( 5895 ), 89 – 92 ( 1983 ).
   PubMed Web of Science ®Google Scholar
• Ehrlich M . DNA hypomethylation in cancer cells . Epigenomics1 ( 2 ), 239 – 259 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hamm CA , XieH , CostaFFet al. Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2′-deoxycytidine results in increased tumorigenicity . PLoS ONE4 ( 12 ), e8340 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yang AS , EstecioMR , DoshiK , KondoY , TajaraEH , IssaJP . A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements . Nucleic Acids Res.32 ( 3 ), e38 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Hamm CA , StevensJW , XieHet al. Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors . BMC Cancer10 , 471 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Breitkreutz D , Diaz de LeonL , PagliaL , GayS , SwarmRL , SternR . Histological and biochemical studies of a transplantable rat chondrosarcoma . Cancer Res.39 ( 12 ), 5093 – 5100 ( 1979 ).
   PubMed Web of Science ®Google Scholar
• Kenan S , SteinerGC . Experimental transplantation of the Swarm rat chondrosarcoma into bone: radiological and pathological studies . J. Orthop. Res.9 ( 3 ), 445 – 451 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Grimaud E , DamiensC , RousselleAV , PassutiN , HeymannD , GouinF . Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma . Histol. Histopathol.17 ( 4 ), 1103 – 1111 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Kulis M , EstellerM . DNA methylation and cancer . Adv. Genet.70 , 27 – 56 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Jin Z , HanYX , HanXR . Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma . J. Mol. Histol.44 ( 6 ), 645 – 652 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Asp J , SangiorgiL , InerotSEet al. Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues . Int. J. Cancer.85 ( 6 ), 782 – 786 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Ropke M , BoltzeC , NeumannHW , RoessnerA , Schneider-StockR . Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma . Pathol. Res. Pract.199 ( 6 ), 437 – 444 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bui C , OuzzineM , TalhaouiIet al. Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells . FASEB J.24 ( 2 ), 436 – 450 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Liggett WH Jr , SidranskyD . Role of the p16 tumor suppressor gene in cancer . J. Clin. Oncol.16 ( 3 ), 1197 – 1206 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Poulain FE , YostHJ . Heparan sulfate proteoglycans: a sugar code for vertebrate development?Development142 ( 20 ), 3456 – 3467 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Guilhamon P , EskandarpourM , HalaiDet al. Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2 . Nat. Commun.4 , 2166 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Azzi G , VelezM , Mathias-MachadoMC . Isocitrate dehydrogenase mutations in chondrosarcoma: the crossroads between cellular metabolism and oncogenesis . Curr. Opin. Oncol.26 ( 4 ), 403 – 407 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lu C , VennetiS , AkalinAet al. Induction of sarcomas by mutant IDH2 . Genes Dev.27 ( 18 ), 1986 – 1998 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Li J , ShenJ , WangK , HornicekF , DuanZ . The roles of Sox family genes in sarcoma . Curr. Drug Targets PMID:27138764 ( 2016 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Tang X , LuX , GuoWet al. Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line . Eur. J. Cancer Prev.19 ( 6 ), 466 – 471 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Fanburg-Smith JC , AuerbachA , MarwahaJS , WangZ , RushingEJ . Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases . Hum. Pathol.41 ( 5 ), 653 – 662 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Soderstrom M , BohlingT , EkforsT , NelimarkkaL , AroHT , VuorioE . Molecular profiling of human chondrosarcomas for matrix production and cancer markers . Int. J. Cancer100 ( 2 ), 144 – 151 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Matsuura S , IshiiT , EndoMet al. Epithelial and cartilaginous differentiation in clear cell chondrosarcoma . Hum. Pathol.44 ( 2 ), 237 – 243 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fitzgerald MP , GourroncF , TeohMLet al. Human chondrosarcoma cells acquire an epithelial-like gene expression pattern via an epigenetic switch: evidence for mesenchymal-epithelial transition during sarcomagenesis . Sarcoma2011 , 598218 ( 2011 ).
   PubMedGoogle Scholar
• Lujambio A , RoperoS , BallestarEet al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells . Cancer Res.67 ( 4 ), 1424 – 1429 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Sun R , ShenJK , ChoyE , YuZ , HornicekFJ , DuanZ . The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcoma . Discov. Med.20 ( 111 ), 311 – 324 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Li J , WangL , LiuZet al. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9 . Oncotarget6 ( 28 ), 26216 – 26229 ( 2015 ).
   PubMedGoogle Scholar
• Mak IW , SinghS , TurcotteR , GhertM . The epigenetic regulation of SOX9 by miR-145 in human chondrosarcoma . J. Cell Biochem.116 ( 1 ), 37 – 44 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chin L , GrayJW . Translating insights from the cancer genome into clinical practice . Nature452 ( 7187 ), 553 – 563 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hamm CA , CostaFF . Epigenomes as therapeutic targets . Pharmacol. Ther.151 , 72 – 86 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Braiteh F , SorianoAO , Garcia-ManeroGet al. Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers . Clin. Cancer Res.14 ( 19 ), 6296 – 6301 ( 2008 ).
   PubMed Web of Science ®Google Scholar